Abstract
Summary
The increments in plasma triglyceride levels observed after administration of Triton were consistently and significantly lower in tetracycline-injected rats, when hepatic tetracycline concentration was high, than in Triton-injected controls. These data are interpreted as indicating impaired release of hepatic triglyceride in tetracycline-injected animals. Hepatic triglyceride increased in tetracycline-injected rats and most of this could be accounted for by impaired release of liver triglyceride. This mechanism, possibly due to impaired synthesis of hepatic lipid acceptor protein, appears to be the major cause of tetracycline-induced fatty liver.
Get full access to this article
View all access options for this article.